Clinical Trial Update: A Multi-Site Study of MDMA-Assisted Psychotherapy for Eating Disorders [Phase 2]

View source ↗

Summary

A Phase 2 multi-site trial of MDMA-assisted psychotherapy for eating disorders has been withdrawn from recruitment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anorexia Nervosa
• Binge Eating Disorder

Drugs mentioned

• MDMA (3,4-methylenedioxymethamphetamine)

Snippet

Sponsor: Lykos Therapeutics | Conditions: Anorexia Nervosa Restricting Type, Binge-Eating Disorder | Phase 2 | Status: WITHDRAWN